Abstract
OBJECTIVE:
Children hospitalized for asthma exacerbations may require escalation of therapy (EOT), but risk factors remain poorly defined. We aimed to identify risk factors for EOT to inform interventions and improve care.
PATIENTS AND METHODS:
We conducted a retrospective cohort study using the Pediatric Health Information System of hospitalized children aged 4 to 18 years with a diagnosis of an asthma exacerbation from January 1, 2018, to December 31, 2023, across 45 children’s hospitals. EOT was defined as intensive care unit transfer, advanced respiratory support, or adjunctive asthma therapy (ie, magnesium sulfate, methylprednisolone) after the first hospital day. Mixed-effects regression estimated the association between EOT and risk factors: age, sex, race and ethnicity, insurance, Child Opportunity Index (COI), complex chronic conditions (CCC), and season.
RESULTS:
Among 92 224 encounters, 15 989 (17.34%) required EOT. Adjusted analysis showed lower odds of EOT in male patients (adjusted odds ratio [aOR], 0.91 [CI, 0.88, 0.94]) and spring compared with summer admissions (aOR, 0.93 [0.88, 0.99]). Compared with early childhood (<5 years), the odds of EOT were higher in late childhood (5–12 years) (aOR, 1.19 [1.13, 1.26]), adolescence (13–17 years) (aOR, 1.48 [1.38, 1.59]), and adults (≥18 years) (aOR, 1.43 [1.17, 1.73]). Higher odds were observed in Hispanic (aOR, 1.07 [1.00, 1.14]) and multiracial (aOR, 1.17 [1.02, 1.34]) patients and those with CCC (aOR, 2.07 [1.95, 2.19]). COI and insurance were not significantly associated with EOT.
CONCLUSION:
We identified key risk factors for EOT in children hospitalized for asthma exacerbations. Such findings can help with early risk stratification or serve as proxies for modifiable features of inpatient care. Further research is warranted to explore these associations to improve care.
INTRODUCTION
Asthma is a leading cause of pediatric hospitalizations in the United States and disproportionately impacts Black and Hispanic children and those living in high-poverty neighborhoods.1–5 Although hospitalization rates have declined across all racial and ethnic groups over time, disparities persist for these populations.2,6 Such differential outcomes often reflect structural racism and unequal access to resources rather than biological variation. Both individual risk factors, such as age, sex, and comorbidities, as well as broader structural inequities, including limited access to care, and neighborhood disadvantage affect asthma health outcomes.7–13 Understanding how these intersecting risk factors contribute to the hospital course is essential to identifying children at highest risk for adverse outcomes and developing equitable and timely interventions.
Escalation of therapy (EOT) refers to an increase in intensity or complexity of medical management initiated in response to clinical deterioration or inadequate therapeutic response during a patient’s hospitalization.14 EOT, including intensive care unit (ICU) transfer and the use of advanced respiratory support or adjunctive therapies (methylprednisolone, theophylline, etc), is an indication of clinical severity, system level processes, and clinician variation.15,16 Factors such as illness severity, treatment response, failure of early recognition of disease progression, quality of care, and resource availability influence the need for EOT in a hospitalized child.15,16 Across pediatric populations, ICU transfer or rapid response team (RRT) activations as types of EOT were associated with longer lengths of stay, higher cost, and greater risk of mortality.17–19 Those who require EOT from the general unit to the ICU have worse outcomes then those admitted directly to the ICU.17,20,21 Understanding these escalation events in the context of pediatric asthma is critical to avoiding subsequent morbidity and unnecessary health care costs, given the disproportionate hospital utilization associated with severe asthma exacerbations.
ICU transfer alone is an incomplete proxy of EOT in asthma, as it may reflect prehospital illness severity. Additionally, criteria for ICU transfer are variable and dependent on institutional policies and resources, such that many children receive higher levels of care outside of ICU settings.4,22 Thus, a broader definition of EOT, encompassing ICU transfer and additional therapies (ie, respiratory support, adjunctive medications), regardless of being in an ICU setting, is needed. Such a definition of EOT captures clinical deterioration and treatment intensity during hospitalization, providing a complementary and potentially more sensitive measure of inpatient severity. Examining risk factors for EOT as a composite measure may help identify potential variations in care and identify patients at higher risk of adverse outcomes. This knowledge can guide health systems in developing targeted interventions, reduce unwarranted variation in practice, and ultimately improve outcomes for children with asthma.
To date, studies assessing EOT as a composite measure for hospitalized children with asthma exacerbations examined limited risk factors and were only conducted outside of the United States. For example, a study in New Zealand and Australia found that those with EOT had longer length of stay.4 However, this study examined only age, sex, and triage category as individual risk factors and did not include known social and environmental factors that influence asthma outcomes. To address this gap, we examined risk factors for EOT among children hospitalized with acute asthma exacerbation in a large US cohort. We hypothesized that younger age, historically marginalized racial and ethnic groups, those with public insurance, and those living in lower-resource neighborhoods would have higher odds of EOT. By clarifying risk factors of EOT, our findings aim to inform risk stratification and highlight opportunities for more equitable inpatient care.
METHODS
Study Design, Participants, and Setting
This is a multicenter retrospective cohort study using the Pediatric Health Information System (PHIS) database of children aged 4 to 18 years admitted to non-ICU settings for asthma exacerbations from January 1, 2018, to December 31, 2023, across 45 children’s hospitals. PHIS is an administrative database containing deidentified clinical and resource utilization data for patient encounters from tertiary pediatric hospitals in the United States that are part of the Children’s Hospital Association (Lenexa, Kansas).23 Participating hospitals provide discharge and encounter data, including demographic, diagnosis, procedure codes, and resource utilization (eg, pharmaceuticals, imaging, and laboratory). Data quality and reliability are assured through a joint effort between the Children’s Hospital Association and participating hospitals.
Patients were identified using any visit diagnosis code for asthma exacerbation or status asthmaticus using the International Classification of Diseases, Tenth Revision (ICD-10) (J45. 21, J4522, J4531, J4532, J4541, J4542, J4551, J4552, J45902, J45990).24,25 We excluded those with All Patient Refined Diagnosis Groups (APR-DRG) codes for cystic fibrosis, pulmonary embolism, and trauma, as well as principal diagnosis codes indicative of disease processes other than asthma (ie, malignant neoplasms, lung transplant, bronchiectasis, acute postprocedure respiratory distress). We excluded encounters without an emergency department charge code, which suggests transfer from another institution. PHIS collects data based on daily billing codes and does not provide timestamps for orders, so the sequence in which care was provided on a given day cannot be determined. Those with ICU charges on the first day of the admission (denoted “day of service 0” or “DOS 0”) were excluded, as we could not distinguish those transferred to the ICU due to EOT from those who were admitted directly to the ICU. Those who received respiratory support or adjunctive therapies (ie, magnesium sulfate, epinephrine, etc) on DOS 0 but were not admitted to the ICU were included in our study population because these therapies may have been used for initial stabilization. This study was deemed non–human participant research by the institutional review board.
Study Outcome and Risk Factors
Our primary outcome measure was EOT, defined as transfer to the ICU, need for respiratory support (high-flow nasal cannula, noninvasive ventilation, continuous or bilevel positive airway pressure, or adjunctive asthma therapy (epinephrine, terbutaline, aminophylline, theophylline, Heliox, magnesium sulfate, or methylprednisolone)22,26,27 after DOS 0.
Individual and environmental risk factors were selected a priori based on prior literature highlighting their association with asthma control or severity, hospitalizations, or ICU admissions and included the following: age, sex, at least 1 complex chronic condition (CCC), insurance status, season, race and ethnicity, and the Child Opportunity Index (COI) 3.0.28–31 Age at admission was categorized using American Academy of Pediatrics developmental stages: early childhood (1 to <5 years), late childhood (5 to <13 years), adolescent (13 to <18 years), and adult (≥18 years). CCC were identified using the CCC 2.0 system, which defines medical complexity based on chronic conditions involving multiple or severely affected organ systems requiring specialty care (ie, technology dependence, cystic fibrosis).32 Asthma is not included in this classification. Insurance categories included commercial, government, and other (including other payor and self-pay) (Supplemental Table 1). Seasons were defined based on months (winter: December to February; spring: March to May; summer: June to August; and fall: September to November). Reference groups were determined a priori.
The COI 3.0 is a composite indicator capturing neighborhood-level social and environmental risk factors across 3 domains: education, health and environment, and social and economic.33,34 The COI composite overall score is categorized in to population-weighted quintiles: very low (1 to 20 percentile), low (21 to 40), moderate (41 to 60), high (61 to 80), and very high (81 to 100).34 A low COI indicates an area of low opportunity for health development and outcomes. The nationally normalized COI 3.0 level is linked within PHIS to the zip code associated with each child per encounter. Those with missing COI scores were excluded from our cohort.
Given that COI may not fully capture the systemic and structural conditions that underlie racial disparities in health outcomes, we included race and ethnicity as a social construct rather than a biological variable to serve as a proxy for interpersonal and structural discrimination at the individual level. Race and ethnicity in PHIS is extracted from electronic health records where assignments are presumed to be based on self-report, although this may vary by institution and attainment is uncertain. Race and ethnicity is categorized as non-Hispanic white, non-Hispanic Black, Asian, American Indian/Alaskan Native, Pacific Islander, Hispanic, multiracial, and other specified. Categories are in alignment with the American Thoracic Society and the National Academy of Sciences, Engineering, and Medicine and the 2023 US Office of Management and Budget standards recommendations for the responsible use of race and ethnicity in research.35–37
Statistical Analysis
Patient characteristics were summarized using standard statistical summaries using frequency (percent) for categorical variables. Mixed-effects logistic regression models were used to estimate the association between our primary outcome and exposures (age, sex, race and ethnicity, CCC, insurance, COI, and season). We accounted for clustering using unique patient and hospital identifiers as random effects. Variance inflation factors were calculated and all covariates demonstrated values less than 2, indicating low collinearity. Adjusted odds ratios (aORs) and 95% CI were used to summarize the association of each risk factor with EOT and a 2-tailed alpha of 0.05 was used to determine significance. All statistical analyses were performed using Stata 18 version (StataCorp LLC, College Station, TX).
RESULTS
Study Characteristics
We extracted a total of 131 284 encounters. We excluded 20 929 (16%) with no emergency department charge, 118 (0.09%) with a missing COI, 184 (0.14%) with APR-DRG codes for cystic fibrosis, pulmonary embolism, and trauma, 201 (0.15%) with a principal diagnosis not suggestive of an asthma admission, and 17 631 (13.43%) who were admitted to the ICU on DOS 0. Our final cohort consisted of 72 968 patients with 92 224 encounters, of which 15 989 (17.34%) required EOT (Table 1). Most children were aged 5 to 12 years (68.2%) and 58.4% were male. There were 43.9% who identified as non-Hispanic Black, 25.27% non-Hispanic white, and 22.4% Hispanic. Most had no CCC (90.7%), had government insurance (65.2%), lived in very low- or low-COI areas (35.1% and 19.4%, respectively), and were admitted in the fall (34.8%).
TABLE 1.
Demographic Characteristics of Pediatric Patients Admitted With Acute Asthma Exacerbation Requiring Escalation of Therapy in 45 Pediatric Hospitals
| Characteristics | Total Sample (N = 92 224) | No Escalation (N = 76 235) | Escalation (N = 15 989) |
|---|---|---|---|
| AAP age categoriesa | |||
| Early childhood (<5 y) | 16 608 (18.0) | 14093 (18.5) | 2515 (15.7) |
| Late childhood (5 y to <13 y) | 62 897 (68.2) | 52 079 (68.3) | 10 818 (67.7) |
| Adolescence (13 y to <18 y) | 11 905 (12.9) | 9420 (12.4) | 2485 (15.5) |
| Adult (≥18 y) | 814 (0.9) | 643 (0.8) | 171 (1.1) |
| Sexb | |||
| Male | 53 824 (58.4) | 44 845 (58.8) | 8979 (56.2) |
| Female | 378 395 (41.6) | 31 386 (41.2) | 7009 (43.8) |
| Race and ethnicityb | |||
| Asian | 2352 (2.6) | 1984 (2.6) | 368 (2.3) |
| Hispanic | 20 382 (22.4) | 16 693 (22.2) | 3689 (23.4) |
| Multiracial | 1948 (2.1) | 1571 (2.1) | 377 (2.4) |
| Non-Hispanic Black | 39 936 (43.9) | 33 063 (43.9) | 6873 (43.6) |
| Non-Hispanic white | 23 012 (25.3) | 19 152 (25.4) | 3860 (24.5) |
| American Indian | 176 (0.2) | 140 (0.2) | 36 (0.2) |
| Pacific Islander | 196 (0.2) | 168 (0.2) | 28 (0.2) |
| Other specified | 3067 (3.4) | 2514 (3.3) | 551(3.5) |
| Insuranceb | |||
| Commercial | 26 314 (28.6) | 21 761 (28.6) | 4553 (28.6) |
| Government: Medicaid/other gov | 59 890 (65.2) | 49 380 (65.0) | 10 510 (66.0) |
| Other (other payor/self-pay) | 5671 (6.2) | 4800 (6.3) | 871 (5.5) |
| Complex chronic conditions | |||
| No complex chronic condition | 83 650 (90.7) | 70 029 (91.8) | 13 621 (85.2) |
| ≥1 complex chronic condition | 8574 (9.3) | 6206 (8.1) | 2368 (14.8) |
| Child Opportunity Index 3.0 | |||
| Very low | 32 392 (35.1) | 26 751 (35.1) | 5641 (35.7) |
| Low | 17 881 (19.4) | 14 798 (19.4) | 3083 (19.2) |
| Moderate | 15 487 (16.8) | 12 797 (16.8) | 2690 (16.7) |
| High | 14 509 (15.7) | 12 045 (15.8) | 2646 (15.4) |
| Very high | 11 955 (13.0) | 9844 (12.9) | 2111 (13.2) |
| Season | |||
| Winter | 22 908 (24.8) | 19 044 (25.0) | 3864 (24.2) |
| Spring | 22 777 (24.7) | 19 011 (24.9) | 3766 (23.6) |
| Summer | 14 475 (15.7) | 1 1 926 (15.6) | 2549 (15.9) |
| Fall | 32 064 (34.8) | 26 254 (34.4) | 5810 (36.3) |
Abbreviation: AAP, American Academy of Pediatrics.
Reported as n (%) unless otherwise stated.
Age range for the study is 4 to 18 years. The “early childhood” group contains those who are aged 4 years only and the “adult” category contains those who are aged 18 years only.
Missing data: race and ethnicity (n = 1157; 1.25%), sex (n = 5, 0.01%), and insurance (n = 349; 0.38%).
Multivariable Regression
Table 2 illustrates results from our multivariable mixed-effects regression model. We observed higher odds of EOT for older children. Compared with children in early childhood, those in late childhood had 19% higher odds (CI, 1,13, 1.26) of EOT, adolescents had 48% higher odds (CI, 1.38, 1.59), and young adults had 43% higher odds (CI, 1.17, 1.73). Male compared with female children had lower odds of EOT (aOR, 0.91 [CI, 0.88, 0.94]). We observed higher odds of EOT for Hispanic (aOR, 1.07 [1.00, 1.14]) or multiracial (aOR, 1.17 [1.02, 1.34]) patients compared with non-Hispanic white and for those with a CCC (aOR, 2.07 [1.95, 2.19]). Compared with summer, spring admissions had lower odds (aOR, 0.93 [0.88, 0.99]) and fall admissions had higher odds (aOR, 1.06 [1.00, 1.12]) of EOT. No significant associations were found between EOT and COI and insurance.
TABLE 2.
Mixed-Effects Logistic Regression Model of Escalation of Therapy in Pediatric Patients Admitted With Acute Asthma Exacerbation (N = 90 722 Encounters; 71 730 Patients)
| Variable | Adjusted Odds Ratio | 95% CI | P Value |
|---|---|---|---|
| AAP age categoriesa | |||
| Early childhood (<5 y) | Ref | ||
| Late childhood (5 y to <13 y) | 1.19 | 1.13, 1.26 | <.001b |
| Adolescence (13 y to <18 y) | 1.48 | 1.38, 1.59 | <.001b |
| Young adult (≥18 y) | 1.43 | 1.17, 1.73 | <.001b |
| Sex | |||
| Female | Ref | ||
| Male | 0.91 | 0.88, 0.94 | <.001b |
| Race and ethnicity | |||
| Non-Hispanic white | Ref | ||
| Asian | 0.92 | 0.81, 1.05 | .22 |
| Hispanic | 1.07 | 1.00, 1.14 | .04b |
| Multiracial | 1.17 | 1.02, 1.34 | .02b |
| Non-Hispanic Black | 1.03 | 0.97, 1.08 | .34 |
| American Indian | 1.25 | 0.83, 1.89 | .29 |
| Pacific Islander | 1.00 | 0.64, 1.58 | .98 |
| Other specified | 1.00 | 0.89, 1.13 | .91 |
| Complex chronic conditions | |||
| No complex chronic conditions | Ref | ||
| ≥1 Complex chronic conditions | 2.07 | 1.95, 2.19 | <.001b |
| Insurance | |||
| Commercial | Ref | ||
| Government insurance | 1.03 | 0.99, 1.07 | .22 |
| Other (other payor/self-pay) | 1.00 | 0.91, 1.10 | .95 |
| Child Opportunity Index | |||
| Very low | 1.00 | 0.94, 1.07 | .90 |
| Low | 1.03 | 0.96, 1.11 | .37 |
| Moderate | 0.99 | 0.93, 1.07 | .91 |
| High | 0.97 | 0.90, 1.05 | .44 |
| Very high | Ref | ||
| Season | |||
| Summer | Ref | ||
| Fall | 1.06 | 1.00, 1.12 | .04b |
| Spring | 0.93 | 0.88, 0.99 | .02b |
| Winter | 0.97 | 0.92, 1.04 | .40 |
Abbreviation: AAP, American Academy of Pediatrics.
Unique patient and hospital identifiers used as random effects.
Age range for the study is 4 to 18 years. Early childhood category contains those who are aged 4 years and adult category contains those who are aged 18 years only.
Statistically significant.
DISCUSSION
In this large retrospective analysis, we identified key risk factors associated with EOT for children hospitalized with asthma exacerbations. Children who were older, were female, were Hispanic or multi-racial, had a CCC, or were admitted in the fall had increased odds of EOT. Interestingly, odds of EOT were lower in spring admissions compared with summer, and there was no association between EOT and COI or insurance status. To our knowledge, this is the first study in the United States to assess individual and environmental risk factors for EOT in pediatric asthma hospitalizations. Our inclusive definition of EOT provides a more sensitive measure of inpatient severity that may better reflect variation in care and opportunities for earlier recognition and intervention.
Our study builds on prior research by identifying important individual factors associated with EOT. To our knowledge, only Craig et al assessed EOT as a comprehensive measure in pediatric patients with asthma and similarly reported an association between EOT and older age.4 Their study also demonstrated that the type of EOT varied by age, with older children more likely to receive parenteral treatment.4 One plausible explanation is that older children may have higher rates of allergen exposure and sensitization leading to higher illness severity and clinical deterioration.8,38 By contrast, studies assessing ICU transfer or RRT activations only have not identified significant age associations.19,39 We also found that female children had higher odds of EOT compared with male children, a finding not observed by Craig et al. Although asthma is more prevalent and results in more hospitalizations in male children,40 prevalence and morbidity shift in adolescence, rising in female and declining in male children.41 Adolescent female individuals also experience more severe asthma, with higher rates of underdiagnosis and undertreatment.42,43 These findings underscore the importance of age- and sex-specific considerations in inpatient asthma care. Awareness that older children and adolescent female individuals may be at higher risk for EOT can guide earlier risk stratification, targeted monitoring, anticipatory management, and caregiver discussions. Incorporating such insights into decision-making may optimize resource allocation and improve outcomes.
Our study further evaluates additional individual (CCC, race and ethnicity, insurance) and environmental (COI, season) risk factors for EOT among children hospitalized with asthma. Children with CCC have been reported to account for up to 38% of hospitalized children in tertiary hospitals and are growing in number.44,45 Additionally, children with CCC have longer LOS and higher resource utilization.46,47 Although children with CCC account for a small percentage of our study population, they had significantly higher odds of EOT. Although not previously reported in studies of comprehensive EOT measures, similar findings were seen in studies assessing acute clinical deterioration events, not limited to asthma.39,48 Their comorbidities and functional limitations may worsen exacerbations and obscure typical signs of respiratory distress, complicating clinical assessment and increasing odds of EOT. Tools commonly used to evaluate asthma severity during hospitalization have not been validated in children with CCC and may not adequately capture their baseline complexity or acute clinical changes. Further research is needed to clarify asthma progression in children with CCC and to develop more appropriate inpatient assessment and management strategies for this growing population.
We found that Hispanic and multiracial patients had higher odds of EOT compared with non-Hispanic white patients, contributing to the literature on inequity in inpatient asthma care. These findings align with prior work highlighting racial and ethnic disparities with prehospital (ie, higher illness severity) and posthospital (ie, increased health utilization) asthma outcomes.2,13,49 Racial disparities also exist within inpatient outcomes such as adverse patient events and acute deterioration among non–asthma-specific cohorts.50,51 Racial disparities observed may reflect the influence of systemic and structural racism.6,36,49,52 Neighborhood-level social needs indices, such as the COI, capture social inequities in housing, education, and community resources.10,53–56 Low COI has been associated with adverse outcomes including higher illness severity, ICU admissions, and longer hospital stay in children with asthma.10,53–58 Surprisingly, however, we found no association with EOT. This aligns with Byrne et al, who found no association between COI and markers of inpatient asthma severity, suggesting that standardized care may mitigate neighborhood-level social differences.13 However, several limitations of the COI should be considered. First, the potential for ecologic fallacy exists, as neighborhood-level indices may not accurately reflect individual social needs that influence asthma severity and care.59–63 Second, although the COI serves as a proxy for structural and neighborhood-level inequities, it may not fully capture the systemic or implicit biases within the hospital system that may contribute to disparities observed among Hispanic and Black children in our cohort. Lastly, inequities during hospitalization related to language barriers or health literacy across racial groups are not captured in the COI or in PHIS. These limitations highlight the need to interpret neighborhood-level indices cautiously while also considering individual-level and structural factors that influence asthma out-comes.7,28–31 Future studies should conduct subgroup analysis and explore causal pathways to disentangle the intersection of race and social factors. Better characterizing individual social needs of children requiring EOT may reveal systemic biases contributing to racial inequities and inform strategies to improve health outcomes.
Lastly, we observed seasonal variability in odds of EOT, with lower odds in the spring and higher odds in the fall compared with the summer. Seasonal variability of asthma is well known, with higher rates of admission and increased severity in the fall and winter, likely due to increased exposure to viruses and indoor allergens.64–66 Higher illness severity in the fall may contribute to higher odds of EOT in our cohort. Interestingly, odds of EOT were lower in the spring compared with the summer. To our knowledge, no literature has described this association. One hypothesis is that staffing variations across the year, such as fewer respiratory therapists during a lower summer census or introduction of new house staff who are less experienced in asthma care, may prompt earlier escalation. Further research is needed to clarify seasonal differences and underlying contributors to EOT.
Our study had several limitations. First, PHIS is an administrative database lacking detailed variables or information to determine severity, and it does not capture other measures of EOT such as RRT activations. Second, PHIS cannot distinguish between patients transferred to the ICU on DOS 0 from those directly admitted to the ICU. The threshold for EOT may differ between institutions, and additional features of EOT may not have been captured. However, our measure still represents worsening clinical status requiring a higher level of care. Additionally, ICD-10 codes were used to identify patients with acute asthma exacerbation or status asthmaticus, which may introduce misclassification bias due to coding inaccuracies or variable documentation practices.67 Such errors are likely nondifferential, biasing results toward the null. Although the COI 3.0 accounts for health insurance rates and some measures of health care accessibility, some dimensions of health care and environmental context may not be captured. Lastly, some results were of borderline statistical significance and should be considered hypothesis generating rather than definitive.
Most existing studies assess risk factors for ICU transfer, with only 1 examining broader predictors of EOT, leaving gaps in our understanding of EOT across the inpatient continuum. ICU transfer is an incomplete proxy for EOT, overlooking children needing higher levels of care outside of the ICU due to variable institutional policies or resources. Our study highlights associations between EOT and risk factors, including older age, male sex, race and ethnicity, presence of CCC, and seasonality. These factors are important for risk stratification and may serve as proxies for modifiable aspects of care, such as monitoring practices and severity assessment tools. Understanding how these factors influence clinical decision-making can inform targeted strategies to reduce escalation, optimize resource utilization, lower health care cost, and improve outcomes. Future research should prioritize subgroup analyses exploring casual pathways and examine modifiable features of inpatient care to identify actionable opportunities to reduce disparities and optimize care for children with asthma.
Supplementary Material
Acknowledgments
We wish to acknowledge Allison Foy, MSN, RN, Business Intelligence Analyst at the Children’s Hospital Association, for her partnership and support with PHIS data extraction.
FUNDING:
Support for Florinda Islamovic was provided by an NHLBI training grant (T32HL172255; MPI Reznik [contact PI]; Isasi). Funding support is also provided by Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at Einstein and Montefiore (UM1TR004400). Jonathan Gabbay, MD, was supported by the K12 Career Development Award from the ICTR at Albert Einstein College of Medicine (K12TR004411).
The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. The funding organizations had no role in the design, preparation, review, or approval of this paper.
ABBREVIATIONS
- aOR
adjusted odds ratio
- APR-DRG
All Patient Refined Diagnosis Groups
- CCC
complex chronic conditions
- COI
Child Opportunity Index
- DOS
day of service
- EOT
escalation of therapy
- ICD-10
International Classification of Diseases, Tenth Revision
- ICU
intensive care unit
- PHIS
Pediatric Health Information System
- RRT
rapid response team
Footnotes
CONFLICT OF INTEREST DISCLOSURES: Dr Reznik is currently receiving grant support from the National Institutes of Health (NIH), Stony Wold-Herbert Fund, and Monaghan Medical Corporation.
REFERENCES
- 1.Centers for Disease Control and Prevention (CDC). Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001–2009. MMWR Morb Mortal Wkly Rep. 2011;60(17):547–552. PubMed [PubMed] [Google Scholar]
- 2.Binney S, Flanders WD, Sircar K, Idubor O. Trends in US pediatric asthma hospitalizations, by race and ethnicity, 2012–2020. Prev Chronic Dis. 2024;21:E71. PubMed doi: 10.5888/pcd21.240049 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Zahran HS, Bailey CM, Damon SA, Garbe PL, Breysse PN. Vital signs: asthma in children—United States, 2001–2016. MMWR Morb Mortal Wkly Rep. 2018;67(5):149–155. PubMed doi: 10.15585/mmwr.mm6705e1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Craig S, Powell CVE, Nixon GM, et al. Treatment patterns and frequency of key outcomes in acute severe asthma in children: a Paediatric Research in Emergency Departments International Collaborative (PREDICT) multicentre cohort study. BMJ Open Respir Res. 2022;9(1):e001137. PubMed doi: 10.1136/bmjresp-2021-001137 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kaiser SV, Rodean J, Coon ER, Mahant S, Gill PJ, Leyenaar JK. Common diagnoses and costs in pediatric hospitalization in the US. JAMA Pediatr. 2022;176(3):316–318. PubMed doi: 10.1001/jamapediatrics.2021.5171 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Allen PS, Mickel NM. Exploring race, racism, and structural racism in medicine. Dermatol Clin. 2023;41(2):345–350. PubMed doi: 10.1016/j.det.2022.08.005 [DOI] [PubMed] [Google Scholar]
- 7.Washington DM, Curtis LM, Waite K, Wolf MS, Paasche-Orlow MK. Sociodemographic factors mediate race and ethnicity-associated childhood asthma health disparities: a longitudinal analysis. J Racial Ethn Health Disparities. 2018;5(5):928–938. PubMed doi: 10.1007/s40615-017-0441-2 [DOI] [PubMed] [Google Scholar]
- 8.McDowell KM, Kercsmar CM, Huang B, Guilbert TW, Kahn RS. Medical and social determinants of health associated with intensive care admission for asthma in children. Ann Am Thorac Soc. 2016; 13(7):1081–1088. PubMed doi: 10.1513/AnnalsATS.201512-798OC [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Belessis Y, Dixon S, Thomsen A, et al. Risk factors for an intensive care unit admission in children with asthma. Pediatr Pulmonol. 2004;37(3):201–209. PubMed doi: 10.1002/ppul.10443 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tyris J, Keller S, Parikh K, Gourishankar A. Population-level SDOH and pediatric asthma health care utilization: a systematic review. Hosp Pediatr. 2023;13(8):e218–e237. PubMed doi: 10.1542/hpeds.2022-007005 [DOI] [PubMed] [Google Scholar]
- 11.Telzak A, Fiori KP, Chambers EC, Haughton J, Levano S, Reznik M. Unmet social needs and pediatric asthma severity in an urban primary care setting. Acad Pediatr. 2023;23(7):1361–1367. PubMed doi: 10.1016/j.acap.2023.02.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Sala KA, Carroll CL, Tang YS, Aglio T, Dressler AM, Schramm CM. Factors associated with the development of severe asthma exacerbations in children. J Asthma. 2011;48(6):558–564. PubMed doi: 10.3109/02770903.2011.585411 [DOI] [PubMed] [Google Scholar]
- 13.Byrne A, Hall M, Berry J, et al. Childhood Opportunity Index and outcomes across the care continuum for children with asthma. Hosp Pediatr. 2025;15(3):219–226. PubMed doi: 10.1542/hpeds.2024-007976 [DOI] [PubMed] [Google Scholar]
- 14.Australian Commission on Safety and Quality in Health Care. National Safety and Quality Health Service Standards. 2nd ed. Sydney, NSW: Australian Commission on Safety and Quality in Health Care; 2021. Accessed September 5, 2025. https://www.safetyandquality.gov.au/standards/nsqhs-standards/recognising-and-responding-acute-deterioration-standard/detecting-and-recognising-acute-deterioration-and-escalating-care/action-806 [Google Scholar]
- 15.Gawronski O, Latour JM, Cecchetti C, et al. Escalation of care in children at high risk of clinical deterioration in a tertiary care children’s hospital using the Bedside Pediatric Early Warning System. BMC Pediatr. 2022;22(1):530. PubMed doi: 10.1186/s12887-022-03555-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gawronski O, Parshuram C, Cecchetti C, et al. Qualitative study exploring factors influencing escalation of care of deteriorating children in a children’s hospital. BMJ Paediatr Open. 2018;2(1): e000241. PubMed doi: 10.1136/bmjpo-2017-000241 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Odetola FO, Rosenberg AL, Davis MM, Clark SJ, Dechert RE, Shanley TP. Do outcomes vary according to the source of admission to the pediatric intensive care unit? Pediatr Crit Care Med. 2008;9(1):20–25. PubMed doi: 10.1097/01.PCC.0000298642.11872.29 [DOI] [PubMed] [Google Scholar]
- 18.Nadeau N, Monuteaux MC, Tripathi J, Stack AM, Perron C, Neuman MI. Does timing matter?: Timing and outcomes among early unplanned PICU transfers. Hosp Pediatr. 2021;11(8):896–901. PubMed doi: 10.1542/hpeds.2020-004978 [DOI] [PubMed] [Google Scholar]
- 19.Humphreys S, Totapally BR. Rapid response team calls and unplanned transfers to the pediatric intensive care unit in a pediatric hospital. Am J Crit Care. 2016;25(1):e9–e13. PubMed doi: 10.4037/ajcc2016329 [DOI] [PubMed] [Google Scholar]
- 20.Tripathi S, Kim M. Outcome differences between direct admissions to the PICU from ED and escalations from floor. Hosp Pediatr. 2021;11(11):1237–1249. PubMed doi: 10.1542/hpeds.2020-005769 [DOI] [PubMed] [Google Scholar]
- 21.Tripathi S, Meixsell LJ, Astle M, Kim M, Kapileshwar Y, Hassan N. A longer route to the PICU can lead to a longer stay in the PICU: a single-center retrospective cohort study. J Intensive Care Med. 2022;37(1):60–67. PubMed doi: 10.1177/0885066620969102 [DOI] [PubMed] [Google Scholar]
- 22.Rogerson CM, Hogan AH, Waldo B, White BR, Carroll CL, Shein SL. Wide institutional variability in the treatment of pediatric critical asthma: a multicenter retrospective study. Pediatr Crit Care Med. 2024;25(1):37–46. PubMed doi: 10.1097/PCC.0000000000003347 [DOI] [PubMed] [Google Scholar]
- 23.PHIS. Accessed September 24, 2025. https://www.childrens-hospitals.org/Programs-and-Services/Data-Analytics-and-Research/Pediatric-Analytic-Solutions/Pediatric-Health-Information-System
- 24.Gabbay JM, Bajaj BVM, Fishman MD, et al. Trends in neighborhood opportunity, hospitalizations, and costs for pediatric asthma. Pediatr Pulmonol. 2025;60(7):e71185. PubMed doi: 10.1002/ppul.71185 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Brajcich MR, Bau GE, Tsai W, Birkholz M, Gaensbauer J. Shifting trends in diagnosis of asthma, bronchiolitis, and viral pneumonia in young children. Clin Pediatr (Phila). 2024;63(9):1233–1238. PubMed doi: 10.1177/00099228231216324 [DOI] [PubMed] [Google Scholar]
- 26.Rehder KJ. Adjunct therapies for refractory status asthmaticus in children. Respiratory Care. 2017/06/01 2017;62(6):849–865. doi: 10.4187/respcare.05174 [DOI] [PubMed] [Google Scholar]
- 27.White BR, Miller AG, Baker J, et al. AARC and PALISI clinical practice guideline: pediatric critical asthma. Respir Care. 2025;70(5): 593–609. PubMed doi: 10.1089/respcare.12897 [DOI] [PubMed] [Google Scholar]
- 28.Hogan AH, Carroll CL, Iverson MG, et al. Risk factors for pediatric asthma readmissions: a systematic review. J Pediatr. 2021; 236:219–228.e11. PubMed doi: 10.1016/j.jpeds.2021.05.015 [DOI] [PubMed] [Google Scholar]
- 29.Aggarwal S, Cepalo T, Gill S, et al. Factors associated with future hospitalization among children with asthma: a systematic review. J Asthma. 2023;60(3):425–445. PubMed doi: 10.1080/02770903.2022.2070762 [DOI] [PubMed] [Google Scholar]
- 30.Akande MY, Ramgopal S, Graham RJ, Goodman DM, Heneghan JA. Child Opportunity Index and emergent PICU readmissions: a retrospective, cross-sectional study of 43 U.S. hospitals. Pediatr Crit Care Med. 2023;24(5):e213–e223. PubMed doi: 10.1097/PCC.0000000000003191 [DOI] [PubMed] [Google Scholar]
- 31.McCrory MC, Akande M, Slain KN, et al. ; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network Social Determinants of Health Subgroup. Child Opportunity Index and pediatric intensive care outcomes: a multicenter retrospective study in the United States. Pediatr Crit Care Med. 2024;25(4):323–334. PubMed doi: 10.1097/PCC.0000000000003427 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr. 2014;14(1):199. PubMed doi: 10.1186/1471-2431-14-199 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hall M, Noelke C, Rothenburger A, Harris M. Pursuing healthy development with the Child Opportunity Index. 2023. Accessed November 24, 2025. https://www.childrenshospitals.org/content/analytics/summary/pursuing-healthy-development-with-the-child-opportunity-index
- 34.Noelke C, McArdle N, DeVoe B, et al. Child Opportunity Index 3.0 Technical Documentation. diversitydatakids.org. Brandeis University; 2024. http://diversitydatakids.org/research-library/coi-30-technical-documentation [Google Scholar]
- 35.Lovinsky-Desir S, Riley IL, Bryant-Stephens T, et al. Research priorities in pediatric asthma morbidity: addressing the impacts of systemic racism on children with asthma in the United States. An official American Thoracic Society workshop report. Ann Am Thorac Soc. 2024;21(10):1349–1364. PubMed doi: 10.1513/AnnalsATS.202407-767ST [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.National Academies of Sciences, Engineering, and Medicine. The Use of Race and Ethnicity in Biomedical Research. The National Academies; 2024. Accessed May 6, 2025. https://www.nationalacademies.org/our-work/the-use-of-race-and-ethnicity-in-biomedical-research [Google Scholar]
- 37.Office of Management and Budget. Revisions to Statistical Policy Directive No. 15: Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity. Fed Regist. 2024;89(61):21724–21725. Accessed September 2, 2025. https://www.federalregister.gov/documents/2024/03/29/2024-06469/revisions-to-ombs-statistical-policy-directive-no-15-standards-for-maintaining-collecting-and [Google Scholar]
- 38.Boeschoten SA, Boehmer AL, Merkus PJ, et al. Risk factors for intensive care admission in children with severe acute asthma in the Netherlands: a prospective multicentre study. ERJ Open Res. 2020;6(3):00126–2020. PubMed doi: 10.1183/23120541.00126-2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lucey K, Jones RC, Watson JA, Malakooti M, Stephen RJ. Risk factors for deterioration events in the pediatric acute care setting. Hosp Pediatr. 2024;14(6):e260–e266. PubMed doi: 10.1542/hpeds.2023-007426 [DOI] [PubMed] [Google Scholar]
- 40.Pate CA, Zahran HS. The status of asthma in the United States. Prev Chronic Dis. 2024;21:E53. PubMed doi: 10.5888/pcd21.240005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Fuseini H, Newcomb DC. Mechanisms driving gender differences in asthma. Curr Allergy Asthma Rep. 2017;17(3):19. PubMed doi: 10.1007/s11882-017-0686-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Almqvist C, Worm M, Leynaert B; working group of GA2LEN WP 2.5 Gender. Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy. 2008;63(1):47–57. PubMed doi: 10.1111/j.1398-9995.2007.01524.x [DOI] [PubMed] [Google Scholar]
- 43.Jenkins CR, Boulet LP, Lavoie KL, Raherison-Semjen C, Singh D. Personalized treatment of asthma: the importance of sex and gender differences. J Allergy Clin Immunol Pract. 2022;10(4): 963–971.e3. PubMed doi: 10.1016/j.jaip.2022.02.002 [DOI] [PubMed] [Google Scholar]
- 44.Feinstein JA, Hall M, Davidson A, Feudtner C. Pediatric Complex Chronic Condition System Version 3. JAMA Netw Open. 2024;7(7): e2420579. PubMed doi: 10.1001/jamanetworkopen.2024.20579 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Simon TD, Berry J, Feudtner C, et al. Children with complex chronic conditions in inpatient hospital settings in the United States. Pediatrics. 2010;126(4):647–655. PubMed doi: 10.1542/peds.2009-3266 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Sharp EA, Wang L, Hall M, Berry JG, Forster CS. Frequency, characteristics, and outcomes of patients requiring early PICU readmission. Hosp Pediatr. 2023;13(8):678–688. PubMed doi: 10.1542/hpeds.2022-007100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Berry JG, Hall M, Neff J, et al. Children with medical complexity and Medicaid: spending and cost savings. Health Aff (Millwood). 2014;33(12):2199–2206. PubMed doi: 10.1377/hlthaff.2014.0828 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Meulmester KM, Jaimon N, Bavare AC. Repeat rapid response events in children: characteristics and outcomes. Pediatr Crit Care Med. 2018;19(4):361–368. PubMed doi: 10.1097/PCC.0000000000001457 [DOI] [PubMed] [Google Scholar]
- 49.Sullivan K, Thakur N. Structural and social determinants of health in asthma in developed economies: a scoping review of literature published between 2014 and 2019. Curr Allergy Asthma Rep. 2020;20(2):5. PubMed doi: 10.1007/s11882-020-0899-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Thurtle DP, Daffron SB, Halvorson EE. Patient characteristics associated with voluntary safety event reporting in the acute care setting. Hosp Pediatr. 2019;9(2):134–138. PubMed doi: 10.1542/hpeds.2018-0142 [DOI] [PubMed] [Google Scholar]
- 51.McKay S, Parente V. Health disparities in the hospitalized child. Hosp Pediatr. 2019;9(5):317–325. PubMed doi: 10.1542/hpeds.2018-0223 [DOI] [PubMed] [Google Scholar]
- 52.FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017;18(1):19. PubMed doi: 10.1186/s12910-017-0179-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Grunwell JR, Opolka C, Mason C, Fitzpatrick AM. Geospatial analysis of social determinants of health identifies neighborhood hot spots associated with pediatric intensive care use for life-threatening asthma. J Allergy Clin Immunol Pract. 2022;10(4):981–991.e1. PubMed doi: 10.1016/j.jaip.2021.10.065 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Grunwell JR, Travers C, Fitzpatrick AM. Inflammatory and comorbid features of children admitted to a PICU for status asthmaticus. Pediatr Crit Care Med. 2018;19(11):e585–e594. PubMed doi: 10.1097/PCC.0000000000001695 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Najjar N, Opolka C, Fitzpatrick AM, Grunwell JR. Geospatial analysis of social determinants of health identifies neighborhood hot spots associated with pediatric intensive care use for acute respiratory failure requiring mechanical ventilation. Pediatr Crit Care Med. 2022;23(8):606–617. PubMed doi: 10.1097/PCC.0000000000002986 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Beck AF, Huang B, Wheeler K, Lawson NR, Kahn RS, Riley CL. The Child Opportunity Index and disparities in pediatric asthma hospitalizations across one Ohio metropolitan area, 2011–2013. J Pediatr. 2017;190:200–206.e1. PubMed doi: 10.1016/j.jpeds.2017.08.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Heneghan JA, Goodman DM, Ramgopal S. Hospitalizations at United States children’s hospitals and severity of illness by neighborhood Child Opportunity Index. J Pediatr. 2023;254:83–90.e8. PubMed doi: 10.1016/j.jpeds.2022.10.018 [DOI] [PubMed] [Google Scholar]
- 58.Gabbay JM, Mayourian J, Bajaj BVM, Wu AC, Graham RJ, Perez JM. Child opportunity and outcomes in pediatric critical asthma: a multicenter analysis. J Allergy Clin Immunol Pract. 2024;12(8):2187–2189. PubMed doi: 10.1016/j.jaip.2024.04.051 [DOI] [PubMed] [Google Scholar]
- 59.Telzak A, Levano S, Haughton J, Chambers EC, Fiori KP. Understanding individual health-related social needs in the context of area-level social determinants of health: the case for granularity. J Clin Transl Sci. 2024;8(1):e78. PubMed doi: 10.1017/cts.2024.519 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Bensken WP, McGrath BM, Gold R, Cottrell EK. Area-level social determinants of health and individual-level social risks: assessing predictive ability and biases in social risk screening. J Clin Transl Sci. 2023;7(1):e257. PubMed doi: 10.1017/cts.2023.680 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Brown EM, Franklin SM, Ryan JL, et al. Assessing area-level deprivation as a proxy for individual-level social risks. Am J Prev Med. 2023;65(6):1163–1171. PubMed doi: 10.1016/j.amepre.2023.06.006 [DOI] [PubMed] [Google Scholar]
- 62.Islamovic F, Levano S, Muleta H, Gabbay JM, Reznik M, Fiori K. Association between the Child Opportunity Index and individual level social risks. J Pediatr Clin Pract. 2025;17:200169. doi: 10.1016/j.jpedcp.2025.200169 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Luke MJ, Kenyon CC, Beck AF, et al. Neighborhood Child Opportunity Index and household-level social needs. Pediatrics. 2025;155(5):e2024069735. PubMed doi: 10.1542/peds.2024-069735 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Cohen HA, Blau H, Hoshen M, Batat E, Balicer RD. Seasonality of asthma: a retrospective population study. Pediatrics. 2014; 133(4):e923–e932. PubMed doi: 10.1542/peds.2013-2022 [DOI] [PubMed] [Google Scholar]
- 65.Beck AF, Huang B, Kercsmar CM, et al. Allergen sensitization profiles in a population-based cohort of children hospitalized for asthma. Ann Am Thorac Soc. 2015;12(3):376–384. PubMed doi: 10.1513/AnnalsATS.201408-376OC [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Khalid M, Almasri T, Goble S, et al. Seasonal variations and social disparities in asthma hospitalizations and outcomes. J Asthma. 2024;61(12):1781–1789. PubMed doi: 10.1080/02770903.2024.2383630 [DOI] [PubMed] [Google Scholar]
- 67.Hall M, Attard TM, Berry JG. Improving cohort definitions in research using hospital administrative databases-do we need guidelines? JAMA Pediatr. 2022;176(6):539–540. PubMed doi: 10.1001/jamapediatrics.2022.0091 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
